Talking about what others are afraid to say
President Trump has reportedly chosen Dr. Heidi Overton to lead the Food and Drug Administration. The decision deserves serious scrutiny—not because Overton lacks intelligence, medical credentials, or familiarity with health …
Heidi Overton Is the Wrong Choice for FDA Commissioner Read More
Every few years, politicians realize that Americans are sick of seeing drug commercials. They convene hearings. They vilify Big Pharma. They call for transparency. They vow to “crack down” on …
No,Washington Won’t Ban Pharma TV Ads Read More
Public-health agencies depend on something they cannot manufacture in a laboratory or compel through regulation: trust. That trust is being tested at a dangerous moment. The United States has recorded …
How the FDA Is Losing Credibility When America Needs It Most Read More
The U.S. Food and Drug Administration just handed a gift to vaccine skeptics—not because the science is wrong, but because the optics are terrible. Reports that the FDA blocked or …
Why Suppressing Vaccine Studies Erodes Public Confidence in the FDA Read More
The FDA’s rejection of Replimune’s RP1 for metastatic melanoma is exactly the kind of decision that erodes trust in the system—among physicians, patients, and frankly, anyone paying attention. This wasn’t …
When the FDA Says “No” After Saying “Yes”: What the RP1 Decision Gets Wrong Read More
For years, pharmaceutical companies have claimed they are committed to “putting patients first.” They say they believe in science. In transparency. In strong regulatory oversight. So why, when the U.S. Food …
The FDA’s Credibility Problem Is Pharma’s Problem Read More
Every few years, the same story makes the rounds in pharma marketing: the FDA is “cracking down” on ads, regulators have turned hostile, and the industry is under attack. It …
The FDA Isn’t at War with Pharma Ads. It’s Just Doing Its Job. Read More
The FDA recently rejected Moderna’s application for its new seasonal flu vaccine. Not because of safety concerns. Not because of efficacy failures. But because, according to the agency, Moderna did …
If you work in pharma, this should make you uneasy Read More